AbbVie’s Love in Mind set to spotlight the emotional impact of Migraines

AbbVie has recently announced the launch of Love in Mind, which is an educational initiative that seeks to elevate the conversation about the emotional impact of living with migraine, beyond the physical symptoms, with a focus on dating and romantic relationships. Migraine is more than just a headache. It is an underdiagnosed, undertreated neurological disease that can cause debilitating pain affecting nearly 40 million Americans.

When Migraine Meets Romance

Note that the Love in Mind survey conducted online by Harris Poll on behalf of AbbVie, took a closer look at how migraine can affect the emotional, social, and romantic lives of 606 adults living with the disease. A few of the key survey findings include:

  • Most survey respondents agreed* it’s hard to feel present in a romantic relationship when experiencing a migraine attack; a reminder that migraine can extend beyond physical symptoms.
  • Love often takes a rain check. More than half of survey respondents have cancelled or rescheduled a date due to migraine attacks. On average, they have done so eight times in the past twelve months.
  • Behind closed doors, the struggle to maintain intimacy can be a challenge. Of those surveyed, 78% of respondents agreed* they sometimes try to push past the pain of migraine attacks to be more physically intimate.

“These survey results highlight how migraine can extend beyond the physical to affect the relationships and moments that matter most, including how we pursue relationships, maintain connection, and view ourselves as romantic partners,” said Aubrey Adams, PhD, therapeutic area head, migraine, medical affairs, AbbVie. “Understanding and acknowledging these impacts is an important part of managing migraine. Open conversations with a healthcare provider about how migraine truly affects daily life – relationships, confidence, and sense of self – can be a meaningful step toward comprehensive care.”



Related Topics and Keywords

, , ,

Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy